KR20140043044A - 국소 투여를 위한 코르티코스테로이드 함유 약학 제형 - Google Patents

국소 투여를 위한 코르티코스테로이드 함유 약학 제형 Download PDF

Info

Publication number
KR20140043044A
KR20140043044A KR1020137016271A KR20137016271A KR20140043044A KR 20140043044 A KR20140043044 A KR 20140043044A KR 1020137016271 A KR1020137016271 A KR 1020137016271A KR 20137016271 A KR20137016271 A KR 20137016271A KR 20140043044 A KR20140043044 A KR 20140043044A
Authority
KR
South Korea
Prior art keywords
concentration
liquid oil
oil component
pharmaceutical composition
corticosteroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137016271A
Other languages
English (en)
Korean (ko)
Inventor
아투로 엔젤
고든 다우
Original Assignee
다우 파마슈티컬 사이언시즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46064916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140043044(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 다우 파마슈티컬 사이언시즈, 인코포레이티드 filed Critical 다우 파마슈티컬 사이언시즈, 인코포레이티드
Publication of KR20140043044A publication Critical patent/KR20140043044A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020137016271A 2010-11-22 2011-11-09 국소 투여를 위한 코르티코스테로이드 함유 약학 제형 Ceased KR20140043044A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45833910P 2010-11-22 2010-11-22
US61/458,339 2010-11-22
PCT/US2011/059861 WO2012087443A1 (en) 2010-11-22 2011-11-09 Pharmaceutical formulations containing corticosteroids for topical administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187002956A Division KR101967121B1 (ko) 2010-11-22 2011-11-09 국소 투여를 위한 코르티코스테로이드 함유 약학 제형

Publications (1)

Publication Number Publication Date
KR20140043044A true KR20140043044A (ko) 2014-04-08

Family

ID=46064916

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137016271A Ceased KR20140043044A (ko) 2010-11-22 2011-11-09 국소 투여를 위한 코르티코스테로이드 함유 약학 제형
KR1020187002956A Active KR101967121B1 (ko) 2010-11-22 2011-11-09 국소 투여를 위한 코르티코스테로이드 함유 약학 제형

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020187002956A Active KR101967121B1 (ko) 2010-11-22 2011-11-09 국소 투여를 위한 코르티코스테로이드 함유 약학 제형

Country Status (20)

Country Link
US (3) US8809307B2 (enExample)
EP (2) EP2643002B1 (enExample)
JP (1) JP6111007B2 (enExample)
KR (2) KR20140043044A (enExample)
CN (1) CN103228281B (enExample)
AU (1) AU2011345240B2 (enExample)
BR (1) BR112013012476B1 (enExample)
CA (2) CA3055328C (enExample)
ES (1) ES2935814T3 (enExample)
HR (1) HRP20230032T1 (enExample)
HU (1) HUE061270T2 (enExample)
IL (1) IL226398B2 (enExample)
LT (1) LT2643002T (enExample)
MX (1) MX346961B (enExample)
NZ (1) NZ610659A (enExample)
PL (1) PL2643002T3 (enExample)
PT (1) PT2643002T (enExample)
RU (1) RU2568598C2 (enExample)
SI (1) SI2643002T1 (enExample)
WO (1) WO2012087443A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) * 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
CN103705441B (zh) * 2012-10-08 2017-06-23 天津金耀集团有限公司 一种丙酸倍氯米松乳膏
CN103705440B (zh) * 2012-10-08 2017-05-10 天津金耀集团有限公司 一种哈西奈德乳膏
US20140112959A1 (en) * 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
CN104095805B (zh) * 2014-01-02 2016-08-24 江苏知原药业有限公司 地奈德乳膏及其制备方法
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US20190133943A1 (en) * 2015-06-18 2019-05-09 Valeant Pharmaceuticals North America Topical compositions and methods for treating skin diseases
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
CN106474052B (zh) * 2016-12-16 2019-10-25 重庆华邦制药有限公司 二丙酸阿氯米松乳膏及其制备方法
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions
CA3133174A1 (en) 2019-03-14 2020-09-17 Crescita Therapeutics Inc. Rinse-off compositions and uses thereof for delivery of active agents
CN115103666A (zh) * 2020-02-11 2022-09-23 塔罗制药工业有限公司 包含去羟米松和他扎罗汀的组合物

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (enExample) 1976-09-29 1978-05-16
NL7105591A (en) 1971-04-24 1972-10-26 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-
DE2655570A1 (de) 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
US4048310A (en) 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4083974A (en) 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
US4233295A (en) * 1979-05-31 1980-11-11 E. R. Squibb & Sons, Inc. Corticosteroid formulations containing sebacate carrier
AU5794680A (en) 1979-05-31 1980-12-04 E.R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
PT73772B (en) * 1980-10-06 1983-10-14 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
JPS58225009A (ja) 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
DE3225848A1 (de) 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
GB8401965D0 (en) 1984-01-25 1984-02-29 Beecham Group Plc Composition
JPH0764734B2 (ja) * 1986-03-17 1995-07-12 大正製薬株式会社 経皮投与製剤
CA1303991C (en) 1986-03-31 1992-06-23 Chung H. Cheng Composition and method for delivering a steroid active ingredient
JPS62238216A (ja) * 1986-04-03 1987-10-19 Otsuka Pharmaceut Factory Inc ステロイドクリ−ム製剤
US5019569A (en) 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
JPH0676328B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイドクリ−ム製剤
JPH0676327B2 (ja) 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH07116026B2 (ja) 1987-07-07 1995-12-13 株式会社資生堂 ジクロフェナックナトリウム含有乳化外用剤
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
DE69116257T2 (de) 1990-03-02 1996-06-27 Shiseido Co Ltd Wässerige emulsion mit nicht steroidhaltigen entzündungshemmenden schmerzmitteln
TW218849B (enExample) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5326566A (en) 1991-05-17 1994-07-05 Bristol-Myers Squibb Company Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
EP0610401A1 (en) * 1991-10-29 1994-08-17 Audio Authority Corporation Apparatus and method for interconnecting electronic products
WO1998036753A1 (en) 1997-02-20 1998-08-27 Allergan Sales,Inc. Tazarotene and corticosteroid treatment for psoriasis
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
SE9800729L (sv) 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
WO2000040250A1 (fr) * 1999-01-06 2000-07-13 Taisho Pharmaceutical Co.,Ltd. Lotion a base d'amelometasone
AU2877800A (en) 1999-02-12 2000-08-29 Susan Bershad Short contact treatment of psoriasis with topical retinoids
PT1194109E (pt) 1999-06-25 2004-12-31 Durham Pharmaceuticals Ltd Formulacoes topicas compreendendo agentes de penetracao na pele e utilizacao dasmesmas
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6579512B2 (en) * 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
US6709663B2 (en) 2001-08-31 2004-03-23 Healthpoint, Ltd. Multivesicular emulsion drug delivery systems
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
ES2298438T3 (es) * 2001-12-21 2008-05-16 Rhodia Inc. Composiciones estables combinadas de tensioactivos cationicos y anionicos.
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
JP2004359585A (ja) 2003-06-03 2004-12-24 Medorekkusu:Kk 被膜形成型の副腎皮質ステロイド薬含有外用製剤
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8449867B2 (en) * 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
WO2006098353A1 (ja) 2005-03-15 2006-09-21 Kyowa Hakko Kogyo Co., Ltd. 外用剤
ES2539634T3 (es) 2005-04-25 2015-07-02 Dow Pharmaceutical Sciences Uso de una formulación de clobetasol en forma de pulverización para tratar la psoriasis
EP1957080A4 (en) 2005-12-09 2013-10-09 Fougera Pharmaceuticals Inc TOPICAL GLUCOCORTICOSTEROID FORMULATIONS
AU2006339350A1 (en) 2005-12-14 2007-09-07 Zars Pharma, Inc. Compositions and methods for dermal delivery of drugs
PL2494959T3 (pl) 2006-07-05 2015-06-30 Foamix Pharmaceuticals Ltd Nośnik ze spienialnego kwasu dikarboksylowego oraz kompozycje farmaceutyczne z nośnikiem
AU2007355106A1 (en) 2006-11-29 2008-12-18 Foamix Ltd. Foamable waterless compositions with modulating agents
US20100323998A1 (en) * 2007-08-06 2010-12-23 Glenmark Pharmaceuticals Ltd. Topical composition containing the combination of mupirocin and beclomethasone
WO2009063493A2 (en) 2007-09-10 2009-05-22 Glenmark Pharmaceuticals Limited Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
WO2009084020A2 (en) 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
KR20160130519A (ko) 2008-06-26 2016-11-11 안테리오스, 인코퍼레이티드 경피 운반
JP5667060B2 (ja) * 2008-10-03 2015-02-12 ネクスメツド・ホールデイングス・インコーポレイテツド 乾癬を治療するための安定化組成物
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
PT2400951T (pt) 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
US20130310355A1 (en) 2009-12-15 2013-11-21 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system
WO2012051614A2 (en) 2010-10-15 2012-04-19 Kulesza John E Delivery of hydrophobic bioactive agents
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US20140112959A1 (en) 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method

Also Published As

Publication number Publication date
NZ610659A (en) 2015-05-29
EP4233838A3 (en) 2023-11-08
CN103228281A (zh) 2013-07-31
MX2013005764A (es) 2013-06-28
PT2643002T (pt) 2023-01-20
MX346961B (es) 2017-04-06
JP6111007B2 (ja) 2017-04-05
EP2643002A1 (en) 2013-10-02
AU2011345240B2 (en) 2016-11-17
US8809307B2 (en) 2014-08-19
ES2935814T3 (es) 2023-03-10
JP2013542990A (ja) 2013-11-28
KR20180015281A (ko) 2018-02-12
CA2817524A1 (en) 2012-06-28
AU2011345240A1 (en) 2013-05-30
RU2013128607A (ru) 2014-12-27
CA3055328A1 (en) 2012-06-28
EP2643002B1 (en) 2023-01-04
EP2643002A4 (en) 2014-07-23
HRP20230032T1 (hr) 2023-03-03
EP4233838A2 (en) 2023-08-30
CA3055328C (en) 2022-09-20
IL226398B (en) 2020-03-31
BR112013012476A2 (pt) 2016-09-06
IL226398B2 (en) 2023-09-01
CN103228281B (zh) 2016-10-19
US20120129824A1 (en) 2012-05-24
HUE061270T2 (hu) 2023-06-28
LT2643002T (lt) 2023-02-10
US20170266288A1 (en) 2017-09-21
KR101967121B1 (ko) 2019-04-08
PL2643002T3 (pl) 2023-04-11
US11213587B2 (en) 2022-01-04
SI2643002T1 (sl) 2023-04-28
RU2568598C2 (ru) 2015-11-20
WO2012087443A1 (en) 2012-06-28
CA2817524C (en) 2019-11-05
US20140336161A1 (en) 2014-11-13
BR112013012476B1 (pt) 2021-03-16
US10478502B2 (en) 2019-11-19

Similar Documents

Publication Publication Date Title
US10478502B2 (en) Pharmaceutical formulations containing corticosteroids for topical administration
US11839656B2 (en) Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
AU2016228574B2 (en) Topical compositions comprising a corticosteroid
BR132017012408E2 (pt) Composto, processo para a preparação de um composto, composições farmacêuticas tópicas estáveis de halobetasol
JP2003212716A (ja) 液晶型乳化組成物
HK40097420A (en) Pharmaceutical formulations containing corticosteroids for topical administration
US20100130460A1 (en) Topical glucocorticosteroid formulations
WO2021046444A1 (en) Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130621

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20161019

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170222

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20170829

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170222

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20170829

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20170424

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20130625

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20171106

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170925

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20170829

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170424

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20170222

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20130625

PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20180130

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20180131